Novel antifungal agents in clinical trials [version 2; peer review: 2 approved]

Invasive fungal diseases due to resistant yeasts and molds are an important and increasing public health threat, likely due to a growing population of immunosuppressed hosts, increases in antifungal resistance, and improvements in laboratory diagnostics.  The significant morbidity and mortality asso...

Ausführliche Beschreibung